Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
500 participants
OBSERVATIONAL
2015-01-31
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma
NCT02238899
Rare Embryonal Tumors of the Central Nervous System: International Registry
NCT05711992
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas
NCT06323408
Memory Neuroimaging in Children, Adolescents and Young Adults Following Pediatric Cancer
NCT04324450
Secondary Central Nervous System Lymphoma Registry - Charité
NCT05114330
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Children and adults with
* Medulloblastoma (MB)
* Ependymoma
* Pineal Tumours
* Chroroid plexus tumours
Objectives of this registry:
To prospectively evaluate the clinical courses of patients with the eligible brain tumours, considering neuroradiological, pathological, and molecular / biological characteristics of the tumour and individual standard treatment data.
To collect biological specimens (tumour, CSF, peripheral blood) or their data to perform biological studies on
* disease aetiology
* molecular / biological risk factors influencing treatment response and survival
* potential targets for drug treatment in future patients
To assess the use of systems for quality assurance during diagnosis and treatment of brain tumours.
To assess long-term follow-up, quality of survival, neuropsychology, and other patient-centred research in these very rare tumour subtypes in the context of the registry or in cooperation with external collaborators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* any localisation of the primary tumour
* all clinical stages
* First diagnosis after 01.01.2012
* No inclusion into a prospective clinical trial for the same diagnosis, due to non-eligibility, national lack of trial approval, or individual refusal of participation.
* Written informed consent for data transfer and tumour sample submission according to the laws of each participating country is necessary.
* National and/ or local ethical committee approval according to the laws of each participating country is necessary.
Exclusion Criteria
* Lack of valid ethical committee approval.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitätsklinikum Hamburg-Eppendorf
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefan Rutkowski, Prof.
Role: PRINCIPAL_INVESTIGATOR
Universitätsklinikum Hamburg-Eppendorf
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Aachen
Aachen, , Germany
Klinikum Augsburg
Augsburg, , Germany
Helios Klinikum Berlin-Buch
Berlin, , Germany
Charite Campus, University of Berlin
Berlin, , Germany
Evangelisches Krankenhaus Bielefeld
Bielefeld, , Germany
Klinikum Braunschweig
Braunschweig, , Germany
Klinikum Bremen-Mitte
Bremen, , Germany
Klinikum Chemnitz
Chemnitz, , Germany
University Hospital Cologne
Cologne, , Germany
Carl-Thiem-Klinikum Cottbus
Cottbus, , Germany
Vestische Kinder- und Jugendklinik, University Witten/Herdecke
Datteln, , Germany
Klinikum Dortmund
Dortmund, , Germany
University Hospital Dresden
Dresden, , Germany
Klinikum Duisburg
Duisburg, , Germany
Universitäts-Kinderklinik Düsseldorf
Düsseldorf, , Germany
HELIOS Klinikum-Erfurt
Erfurt, , Germany
University Hospital Erlangen
Erlangen, , Germany
University Hospital Essen
Essen, , Germany
University Hospital Frankfurt/Main
Frankfurt, , Germany
University Hospital Freiburg
Freiburg im Breisgau, , Germany
Universitätsklinikum Gießen und Marburg
Giessen, , Germany
Georg-August-Universität Göttingen
Göttingen, , Germany
University Hospital Greifswald
Greifswald, , Germany
University Hospital Halle/Saale
Halle, , Germany
University Medical Center Hamburg-Eppendorf
Hamburg, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Angelika-Lautenschläger-Klinik
Heidelberg, , Germany
SLK-Kliniken
Heilbronn, , Germany
Gemeinschaftskrankenhaus Herdecke
Herdecke, , Germany
University Hospital Homburg/Saar
Homburg, , Germany
University Hopsital Jena
Jena, , Germany
Städtisches Klinikum Karlsruhe
Karlsruhe, , Germany
Klinikum Kassel
Kassel, , Germany
UK-SH Campus Kiel
Kiel, , Germany
Gemeinschaftsklinikum Koblenz-Mayen
Koblenz, , Germany
HELIOS Klinikum Krefeld
Krefeld, , Germany
University Hospital Leipzig
Leipzig, , Germany
Universitätsklinikum Schleswig-Holstein
Lübeck, , Germany
University Hospital Magdeburg
Magdeburg, , Germany
University Hospital Mainz
Mainz, , Germany
University Hospital Mannheim
Mannheim, , Germany
Johannes Wesling Klinikum Minden
Minden, , Germany
Universität München - von Haunersches
München, , Germany
Klinikum Schwabing, Pediatric Hospital of Technical University
München, , Germany
Universitätsklinikum Münster
Münster, , Germany
Cnopf'sche Kinderklinik
Nuremberg, , Germany
Klinikum Oldenburg
Oldenburg, , Germany
University Hospital Regensburg
Regensburg, , Germany
University Hospital Rostock
Rostock, , Germany
Asklepios Klinik Sankt Augustin
Sankt Augustin, , Germany
Helios Kliniken Schwerin
Schwerin, , Germany
Klinikum Stuttgart
Stuttgart, , Germany
Universitätsklinik Tübingen
Tübingen, , Germany
University Hospital Ulm
Ulm, , Germany
Dr. Horst Schmidt Kliniken
Wiesbaden, , Germany
Klinikum der Stadt Wolfsburg
Wolfsburg, , Germany
Universotätsklinikum Würzburg
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I-HIT-MED Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.